Drug Profile
Tagorizine
Alternative Names: AL-3264Latest Information Update: 14 Jun 2000
Price :
$50
*
At a glance
- Originator Dainippon Pharmaceutical
- Class Antiasthmatics
- Mechanism of Action 5-lipoxygenase inhibitors; Histamine H1 receptor antagonists; Histamine release inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Allergic rhinitis; Asthma
Most Recent Events
- 14 Jun 2000 Discontinued-III for Allergic rhinitis in Japan (PO)
- 14 Jun 2000 Discontinued-III for Asthma in Japan (PO)
- 05 Jun 1997 Phase-III clinical trials for Allergic rhinitis in Japan (PO)